Tanvex BioPharma, Inc. (TPE:6541)
Taiwan
· Delayed Price · Currency is TWD 40.20
+0.10 (0.25%)
Apr 28, 2026, 1:30 PM CST
-34.10% (1Y)
| Market Cap | 10.65B |
| Revenue (ttm) | 400.97M |
| Net Income (ttm) | -1.50B |
| Shares Out | 264.86M |
| EPS (ttm) | -6.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 302,838 |
| Average Volume | 427,885 |
| Open | 40.15 |
| Previous Close | 40.10 |
| Day's Range | 39.65 - 40.30 |
| 52-Week Range | 39.30 - 68.00 |
| Beta | 0.20 |
| RSI | 40.12 |
| Earnings Date | May 6, 2026 |